Graves Gilbert, Circuit Clinical Launch Clinical Trial Collaboration
With support from LabCorp, partnership aims to bring trials to patients in south central Kentucky.
Graves Gilbert and Circuit Clinical broke the news that they will be collaborating to bring clinical trials to patients in South Central Kentucky. As part of the joint venture, the organizations intend to reduce the burden on patients who opt in for research participation. Localizing research participant care within Graves Gilbert's physician offices, Circuit Clinical supports the care provider team with embedded staff who have clinical trial experience and work side-by-side with the physicians in practice.
According to a company press release, the partnership was made possible through LabCorp. As the primary reference laboratory for Graves Gilbert, LabCorp will help identify clinical trials for which Graves Gilbert patients may be eligible, and the parties will work together to enroll patients into the trials quickly.
"We look forward to continuing to serve our diverse communities by offering patients access to clinical trials and cutting-edge treatments all from the comfort of our offices, with the physicians they know and trust," said Chris Thorn, CEO, Graves Gilbert.
Reference: Graves Gilbert, Circuit Clinical, and Labcorp Join Forces to Bring Clinical Trials to Patients across South Central Kentucky. PR Newswire. September 27, 2023. Accessed September 28, 2023. https://www.prnewswire.com/news-releases/graves-gilbert-circuit-clinical-and-labcorp-join-forces-to-bring-clinical-trials-to-patients-across-south-central-kentucky-301940562.html
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025